DK2403515T3 - Sammensætninger og fremgangsmåder til at forårsage neurit-udvækst - Google Patents

Sammensætninger og fremgangsmåder til at forårsage neurit-udvækst

Info

Publication number
DK2403515T3
DK2403515T3 DK10710598.3T DK10710598T DK2403515T3 DK 2403515 T3 DK2403515 T3 DK 2403515T3 DK 10710598 T DK10710598 T DK 10710598T DK 2403515 T3 DK2403515 T3 DK 2403515T3
Authority
DK
Denmark
Prior art keywords
compositions
methods
neurite outgrowth
causing
causing neurite
Prior art date
Application number
DK10710598.3T
Other languages
Danish (da)
English (en)
Inventor
Yoshinori Takei
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council filed Critical Medical Res Council
Application granted granted Critical
Publication of DK2403515T3 publication Critical patent/DK2403515T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211—Thymidine kinase (2.7.1.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
DK10710598.3T 2009-03-06 2010-03-05 Sammensætninger og fremgangsmåder til at forårsage neurit-udvækst DK2403515T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0903913.2A GB0903913D0 (en) 2009-03-06 2009-03-06 Compositions and methods
PCT/GB2010/000391 WO2010100428A2 (en) 2009-03-06 2010-03-05 Compositions and methods

Publications (1)

Publication Number Publication Date
DK2403515T3 true DK2403515T3 (da) 2014-08-11

Family

ID=40600640

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10710598.3T DK2403515T3 (da) 2009-03-06 2010-03-05 Sammensætninger og fremgangsmåder til at forårsage neurit-udvækst

Country Status (10)

Country Link
US (1) US9089565B2 (OSRAM)
EP (1) EP2403515B1 (OSRAM)
JP (1) JP5670921B2 (OSRAM)
CN (1) CN102341117B (OSRAM)
AU (1) AU2010219463A1 (OSRAM)
CA (1) CA2750911A1 (OSRAM)
DK (1) DK2403515T3 (OSRAM)
ES (1) ES2493619T3 (OSRAM)
GB (1) GB0903913D0 (OSRAM)
WO (1) WO2010100428A2 (OSRAM)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1066378A2 (en) 1998-04-03 2001-01-10 Curagen Corporation Lyst protein complexes and lyst interacting proteins
US6903187B1 (en) * 2000-07-21 2005-06-07 Allergan, Inc. Leucine-based motif and clostridial neurotoxins
WO2003027228A2 (en) * 2001-07-17 2003-04-03 Incyte Genomics, Inc. Receptors and membrane-associated proteins
JP2003093056A (ja) 2001-09-26 2003-04-02 Japan Science & Technology Corp ｐ５３のＳｅｒ４６をリン酸化する酵素
US20070025877A1 (en) 2003-06-03 2007-02-01 Hansen Christian M User interface for portable medical diagnostic apparatus and method of using the same
GB0314943D0 (en) * 2003-06-25 2003-07-30 Proteome Sciences Plc Screening methods
CN1849132A (zh) * 2003-09-10 2006-10-18 伦敦大学国王学院 调节神经元生长的化合物以及它们的用途
EP1695061A4 (en) * 2003-12-16 2008-02-20 Childrens Medical Center METHOD OF TREATING NEUROLOGICAL DISORDERS
US20050214288A1 (en) * 2004-03-26 2005-09-29 Human Genome Sciences, Inc. Antibodies against Nogo receptor
WO2006017673A2 (en) 2004-08-03 2006-02-16 Biogen Idec Ma Inc. Taj in neuronal function
US7414637B2 (en) * 2004-09-10 2008-08-19 Telmap Ltd. Placement of map labels
CA2684321A1 (en) 2007-03-21 2008-09-25 Effat Emamian Compositions comprising pkac fragments and uses thereof for inhibiting akt1, p70s6k or abl activity

Also Published As

Publication number Publication date
WO2010100428A2 (en) 2010-09-10
HK1166017A1 (en) 2012-10-19
ES2493619T3 (es) 2014-09-12
GB0903913D0 (en) 2009-04-22
US9089565B2 (en) 2015-07-28
US20110318326A1 (en) 2011-12-29
CN102341117B (zh) 2015-01-21
JP5670921B2 (ja) 2015-02-18
CA2750911A1 (en) 2010-09-10
EP2403515B1 (en) 2014-05-21
CN102341117A (zh) 2012-02-01
EP2403515A2 (en) 2012-01-11
WO2010100428A3 (en) 2010-10-21
JP2012519676A (ja) 2012-08-30
AU2010219463A1 (en) 2011-09-22

Similar Documents

Publication Publication Date Title
DK3795573T3 (da) Bestemte triazolopyraziner, sammensætninger deraf og fremgangsmåder til anvendelse deraf
DK3812360T3 (da) Monochlortrifluorpropen forbindelser og sammensætninger og metoder, der anvender dem
DK3196309T3 (da) Thraustochytrider, fedtsyresammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
SMT201600307B (it) Composizione liposomiale
FR2941462B1 (fr) Composition decapante
DK2482841T4 (da) Sammensætninger og fremgangsmåder til at forbedre koagulationsfaktor-viii-funktion
BRPI1013588A2 (pt) composição
BR112012004707A2 (pt) método
BR112012000624A2 (pt) método
DK3569256T3 (da) Stabiliserede fibronectin-domænesammensætninger, fremgangsmåder og anvendelser
FI20090389A0 (fi) Menetelmä
BRPI0920284A2 (pt) composição e método
DK3721880T3 (da) Sammensætning og fremgangsmåde til muskelreparation og regenerering
BRPI1015474A2 (pt) composição
DK3128014T3 (da) Midler og fremgangsmåder til sterilisering af biofunktionelle sammensætninger
DK2504353T4 (da) Lipopeptidsammensætninger og tilsvarende fremgangsmåder
PL2356462T3 (pl) Kompozycje anty-CXCR1 oraz sposoby
DK3338790T3 (da) Oligopeptid-forbindelser og anvendelser deraf
BRPI0908547A2 (pt) aparelho comutador
BRPI1012526A2 (pt) método
BRPI1010705A2 (pt) método
DK2310613T3 (da) Forbedret brudled til stigrør
DK3342292T3 (da) Fast mælk og fremgangsmåde til fremstilling deraf
BRPI1012532A2 (pt) método
BRPI0910691A2 (pt) compostos e composições como inibidores de itpkb